H.R. 1672

119th Congress

In Committee

Maintaining Investments in New Innovation Act

Sponsored byDemocrat:Rep. Davis, Donald G. [D-NC-1]NC· Introduced 27 février 2025
Open on Congress.gov

46

Cosponsors

4

Actions

0

Amendments

2

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

27 février 2025·1 year ago

Summary

Introduced in House · Updated 26 mars 2025

Maintaining Investments in New Innovation Act

This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

Timeline

4 actions

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    27 février 2025 · IntroReferral

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    27 février 2025 · IntroReferral

  3. Introduced in House

    27 février 2025 · IntroReferral

  4. Introduced in House

    27 février 2025 · IntroReferral

Sponsorship

46 cosponsors

Sponsor

Democrat:Rep. Davis, Donald G. [D-NC-1]NC

Cosponsors

  • Democrat511%
  • Republican4189%

Classification

Policy area

Health

Legislative subjects

GeneticsMedicarePrescription drugs

Committees

2

  • Energy and Commerce Committee

    House · Standing

    • Referred To27 Feb 2025

  • Ways and Means Committee

    House · Standing

    • Referred To27 Feb 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 13 on 27 février 2025 to 46 on 25 juin 2026.

Pelosi Tracker
Follow on XRejoignez notre Discord
PolitiquesProjets de loiPortefeuillesTarifsÀ proposMentions légalesConditions d'utilisationPolitique de confidentialité
English
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.